Comparison of FOLFOX and DOF regimens as first-line treatment in East Asian patients with advanced gastric cancer

BACKGROUND: Our study retrospectively assesses the safety and efficacy of the FOLFOX (oxaliplatin, fluorouracil, and leucovorin) versus DOF (docetaxel, oxaliplatin, and fluorouracil) regimens in untreated locally advanced gastric cancer (AGC). PATIENTS AND METHODS: A total of 108 patients underwent...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Onco Targets Ther
Egile Nagusiak: Liu, Mengyao, Hu, Guofang, Wang, Yuan, Guo, Jun, Liu, Liyan, Han, Xiao, Wang, Zhehai
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Dove Medical Press 2018
Gaiak:
Original Research
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC5775733/
https://ncbi.nlm.nih.gov/pubmed/29398919
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/OTT.S149624
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak